Dai ichi Life Insurance Company Ltd Sells 3,725 Shares of Cardinal Health, Inc. $CAH

Dai ichi Life Insurance Company Ltd decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 7.8% in the first quarter, Holdings Channel reports. The firm owned 43,994 shares of the company’s stock after selling 3,725 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in Cardinal Health were worth $9,296,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in CAH. Integrated Wealth Concepts LLC raised its holdings in shares of Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after buying an additional 280 shares in the last quarter. Jones Financial Companies Lllp lifted its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership acquired a new stake in Cardinal Health in the 2nd quarter valued at $1,935,000. Cerity Partners LLC grew its position in Cardinal Health by 17.0% in the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after acquiring an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC grew its position in Cardinal Health by 34.4% in the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock valued at $1,736,000 after acquiring an additional 2,646 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Cardinal Health stock opened at $227.96 on Friday. The business’s fifty day moving average is $219.98 and its two-hundred day moving average is $214.43. The firm has a market cap of $53.39 billion, a P/E ratio of 34.86, a P/E/G ratio of 1.11 and a beta of 0.49. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $243.21.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same period last year, the company posted $2.35 earnings per share. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 10.77 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were given a $0.5158 dividend. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date was Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 31.50%.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Morgan Stanley lifted their price objective on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Weiss Ratings cut shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Robert W. Baird set a $248.00 price target on shares of Cardinal Health in a report on Friday, May 1st. TD Cowen boosted their price target on shares of Cardinal Health from $255.00 to $275.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $251.73.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.